News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by greeneggs on Friday June 11, 2021 @12:06PM (#27475091)
Sure, but the doctor doesn't have to do much research in this case. This is front-page news in the NY Times. And about "every single medication": this is the only approved medication to delay clinical decline due to Alzheimer's. And there are only a few medications to treat symptoms.

I know this isn't a perfect world, but it doesn't seem to be asking a lot for a doctor to know this. (Especially for a drug that currently costs $56K/year and presumably will cost more next year.)

[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by setpatchaddress on Friday June 11, 2021 @01:15PM (#27475983)
You seem to have an incredibly optimistic view of the both the medical profession and human attention span.
[ Parent | on HN ]